Invitation to tender for the supply of licensed tenofovir disoproxil / emtricitabine combined tablet formulations for the PrEP IMPACT Trial
What the buyer wrote
This procurement will be conducted by AGCSU on behalf of NHS England Specialised Commissioning. Any contract arising from this procurement will be between the successful Provider and NHS England (National Health Service Commissioning Board). The successful Provider will be awarded the contract included within the tender documents This procurement relates to the supply of licensed tenofovir disoproxil / emtricitabine combined tablet formulations (the Goods) for the PrEP IMPACT Trial. The Supplier appointed as a result of this procurement will be responsible for the supply and delivery of the Goods in accordance with the Specification and Contract, to Trial Sites recruited in to the trial. T…
Details
- What the buyer calls it
- Invitation to tender for the supply of licensed tenofovir disoproxil / emtricitabine combined tablet formulations for the PrEP IMPACT Trial
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 31 Jul 2017
- Work ends
- 31 Jul 2020
Who the buyer named
Angela Deakin was the named contact on this notice.